Efficacy of Epinephrine and Bupivacaine lavage in patients with Displaced Femoral Neck Fractures Undergoing Bipolar Hemiarthroplasty : A Triple Blinded randomized controlled trial

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20230809004

Enrollment

Registered

2023-08-09

Start date

2023-03-10

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Displaced Femoral Neck Fractures Undergoing Bipolar Hemiarthroplasty Epinephrine, Bupivacaine, Femoral Neck Fractures, Bipolar Hemiarthroplasty, Randomized controlled trial

Interventions

Epinephrine 4 mg + Bupivacaine 50 mg in Normal Saline 1,000 ml,Normal saline 1,000 ml

Experimental Drug,Placebo Comparator Other

Epinephrine, Bupivacaine,Normal saline

Eligibility

Sex/Gender

All

Age

60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients with Displaced Femoral Neck Fractures Undergoing Bipolar Hemiarthroplasty 2. Age more than 60 years old 3. BMI less than 35 kg/m2 4. Ambulatory without gaitaid

Exclusion criteria

Exclusion criteria: 1. Multiple trauma 2. Previous hip fracture 3. Pathological fracture 4. History of thromboembolism 5. Allergy to Epinephrine and Bupivacaine

Design outcomes

Primary

Measure	Time frame
Total blood loss 48 hours Milliliter	—

Secondary

Measure	Time frame
Total hemoglobin changed 48 HOURS GRAM/DECILITER	—

Countries

Thailand

Contacts

Public ContactPOOTHAPORN SURACHAT

LERDSIN HOSPITAL

POOTHAPORN.S@GMAIL.COM0880600420

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026